Erratum: Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (Rheumatology (2008) vol. 47 (362-367) 10.1093/rheumatology/kem371);Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort

Rheumatology

Volumn 47, Issue 3, 2008, Pages 362-367

  Apte, M ^a   McGwin Jr , G ^a,b   Vila L M ^c   Kaslow, R A ^a   Alarcón, Graciela S ^a,e   Reveille, J D ^d  

^a The University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e NONE   (United States)

Author keywords

Damage; Lupus; Myocarditis; Survival

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ETHNIC DIFFERENCE; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDITIS; PERICARDITIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

EID: 39449108624     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken134     Document Type: Erratum

References (37)

1. Hahn BH. Systemic Lupus Erythematosus. In: Fauci AS, Braunwald E, Kasper DL et al., eds. Harrison's online. 17th edition. http://www.accessmedicine.com/content.aspx?alD-2858974. Accessed 15 January 2008.
2. Roldan CA. Connective tissue diseases and the heart. in: Crawford MH, ed. Current diagnosis & treatment in cardiology. 2nd edition. McGraw-Hill. http://www.access medicine.com/content.aspx9alD-160914. Accessed 15 January 2008.
3. Szekanecz Z, Shoenfeld Y. Lupus and cardiovascular disease: The facts. Lupus 2006;S15:3-10.
4. Roberts WC, O'Rourke RA, Roldán JF. The connective tissue diseases. In: Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's the heart. 11 edition. McGraw-Hill. http://www.accessmedicine.com/ content.aspx?aiD-264312. Accessed 15 January 2008.
5. Jacobsen S, Petersen J, Ullman S et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinic factors of prognostic value. Clin Rheumatol 1998;17:478-84.
6. Law WG, Thong BY, Lian TY, Kong KO, Chng HH. Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 2005;14:827-31.
7. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y. Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology 2006;45(Suppl 4):iV8-13.
8. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002:113:419-23.
9. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-6.
10. Ansari A, Larson PH, Bates HD. Cardiovascular manifestations of systemic lupus erythematosus: Current perspective. Prog Cardiovasc Dis 1985:27:421-34.
11. Alarcón GS, Friedman AW, Straaton KV et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in Minority populations: NAture vs. nurture. Lupus 1999;8:197-209.
12. Alarcón GS, Roseman J, Bartoluccl AA et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum 1998;41:1173-80.
13. Logar D, Kveder T, Rozman B, Dobovisek J. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in with systemic lupus erythematosus. Ann Rheum Dis 1990;49:627-9.
14. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
15. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
16. Reveille JD, Moulds JM, Ahn C et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, mid CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, Nature versus Nurture. Arthritis Rheum 1998;41:1161-72.
17. U.S. Department of Commerce, Bureau of the Census. Current population reports, Series P-23, No. 28 and Series P-60, No. 68 and subsequent years. Washington, DC: Housing and Household Economic Statistics Division, 1995.
18. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
19. Gladman DD, Goklsrnith CH, Urowitz MB et al The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SUCC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000;27:373-6.
20. Aarden LA, De Groot ER, Feltkamp TE. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann NY Acad Sci 1975;254:505-15.
21. Hamilton RG, Harley JB, Bias WB et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro, (SS-A) autoantibody. Arthritis Rheum 1988;31: 496-505.
22. Harris EN. Special report. The second International anti-cardiolipin standardization workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990,94:476-84.
23. Triplett DA, Bama LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993;70:787-93.
24. Engle EW, Callahan LF, Pincus T, Hochberg MC. Learned helplessness in systemic lupus erythematosus: Analysis using the Rheumatology Attitude Index. Arthritis Rheum 1990;33:281-6.
25. Pilowsky L, Spence ND. Illness Behavior Questionnaire (IBQ). In: Corcoran K, Fischer J, eds. Measures for clinical practice: A source book. New York: The Free Press, 1996:182-5.
26. Cohen S, Mermelstein R, Kamarck T, Hoberman HN. Measuring the functional components of social support. In: Sarason IG, Sarason BR, eds. Social support: Theory, research and applications. Boston: Martinus Nijhoff, 1985:73-94.
27. Kleinbaum D. Survival analysis: A self-learning text. Springer, 1996.
28. Thakker B, Hur K, Henderson WG, Oprian C. A method to generate Kaplan-Meier and adjusted survival curves using SAS, SAS user group international proceedings (SUG123). http://www2.sas.com/proceedings/ sugi123/Stats/p226.pdf. Accessed 15 January 2008.
29. Alarcón GS, McGwin G Jr, Bastian HM et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001;45:191-202.
30. Roberts WC, High ST. The heart in systemic lupus erythematosus. Curr Probl Cardiol 1999;24:1-56.
31. Vilá LM, Alarcón GS, McGwin G et al. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulatilons. Rheumatology 2004;43:358-63.
32. O'Neill TW, Mahmoud A, Tooke A, Thomas RD, Maddison PJ. Is there a relationship between subclinical myocardial abnormalities, conduction defects and Ro/La antibodies in adults with systemic lupus erythemtosus? Clin Exp Rheumatol 1993; 11:409-12.
33. Liang MH, Cullen K, Larson M. In search of a more perfect mousetrap(health status or quality of life instrument). J Rheumatol 1982;9:775-9.
34. Toloza SMA, Roseman JM, Alarcón GS et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXII: Predictors of time to the occurrence of initial damage. Arthritis Rheum 2004;50:3177-86.
35. Alarcón GS, Roseman JM, McGwin G Jr et al. Systemic lupus erythematosus in three ethnic groups: XX. Damage as predictor of further damage. Rheumatology 2004;43:202-5.
36. Alarcón GS, McGwin G Jr, Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001;44:2797-806.
37. Fernández M, Alarcón GS, Calvo-Alén J et al. A multiethnic multicenter cohort of patients with systematic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007;51:576-84.